A study to assess the effectiveness of esomeprazole 40 mg once daily in subjects with continuing gastroesophageal reflux disease (GORD) symptoms following treatment with a previous full dose proton pump inhibitor (PPI). An 8 week, open label, multicentre study The primary objective of this study is to assess the change in the frequency of heartburn from baseline value at entry to the end of the study, after 8-weeks treatment with Esomeprazole 40mg compared ...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Efectividad de quetiapina de liberación prolongada vs sertralina como terapia co-adyuvante al tratamiento eutimizante previo en la depresión bipolar aguda: un estudio piloto Evaluar la efectividad antidepresiva temprana de quetiapina de liberación prolongada(quetiapina LP) vs. sertralina en el tratamiento de pacientes bipolares adultos con un episodio depresivo que aparec...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Efficacy and Safety of Dapagliflozin and Dapagliflozin plus Saxagliptinin in Combination with Metformin in Type 2 Diabetes Patients compared with Sulphonylurea. Skuteczność i bezpieczeństwo stosowania dapagliflozyny i dapagliflozyny w połączeniu z saksagliptyną w porównaniu do pochodnych sulfonylomocznika w terapii dodanej do leczenia metforminą u dorosłych pacjentów z rozpoznaniem cukrzycy typu 2 To compare the absolute change from baseline in HbA1c at Week 52 between dapagliflozin plus metformin and dapagliflozin plus saxagliptin plus metformin with glimepiride plus metformin Porównanie...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Durvalumab+ Gemcitabine/Cisplatin (Neoadjuvant Treatment) and Durvalumab (Adjuvant Treatment) in Patients With MIBC (NIAGARA) A Phase III, Randomized, Open-Label, Multi-Center, Global Study to Determine the Efficacy and Safety of Durvalumab in Combination With Gemcitabine+Cisplatin for Neoadjuvant Treatment Followed by Durva...

• Pays France
• Organes Vessie
• Spécialités Chimiothérapie, Immunothérapie - Vaccinothérapie

Efficacy and safety study of benralizumab added to medium dose inhaled corticosteroid plus LABA in patients with uncontrolled asthma To evaluate the effect of benralizumab on asthma exacerbations in adult patients with uncontrolled asthma

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Comparison of the Effects Noted in The ApoB/ApoA-I ratio Using Rosuvastatin and atorvastatin in patients with acUte coronary Syndrome to compare the efficacy of rosuvastatin 20 mg versus atorvastatin 80 mg in reducing ApoB/ApoA-I ratio at 3 months in acute coronary syndrome (ACS) patients receiving the study treatment after a PCI.

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

A Randomized, Double-Blind, Placebo Controlled, Multicenter, Phase III Study of Rosuvastatin (CRESTOR) 20 mg in the Primary Prevention of Cardiovascular Events Among Subjects with Low Levels of LDL Cholesterol and Elevated Levels of C-Reactive Protein to investigate whether long-term treatment with rosuvastatin 20 mg compared with placebo will decrease the rate (based on time to first event after randomization) of major cardiovascular events (combi...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

A single-blind single arm study to validate the Reflux Disease Questionnaire (RDQ) for the diagnosis of reflux disease in primary care in patients treated with esomeprazole 40 mg o.d The primary objective of this study is to determine the accuracy of the RDQ as a diagnostic test for gastroesophageal reflux disease. Symptom evaluation by the RDQ will be compared with other establis...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

A Study to Investigate How Common Pancreatic Exocrine Insufficiency (PEI) is in Patients with Type 2 Diabetes and also to Investigate the Uptake of a Single Dose of EPANOVA® or OMACOR® in Patients with Different Degrees of PEI The primary objective of Part A of the trial is to describe the distribution of plasma triglycerides in patients with Type 2 Diabetes Mellitus by degree of pancreatic exocrine insufficiency (Normal: f...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

A Phase 2 study to evaluate the effect of Tralokinumab in adults with asthma inadequately controlled on inhaled corticosteroid To evaluate the effect of tralokinumab on eosinophilic airway infiltration in adult subjects with asthma inadequately controlled with ICS.

• Pays Aucun
• Organes Aucun
• Spécialités Aucune